Cite
HARVARD Citation
Mulla, K. et al. (2023). Hyperglycaemia following immune checkpoint inhibitor therapy—Incidence, aetiology and assessment. Diabetic medicine. 40 (4), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mulla, K. et al. (2023). Hyperglycaemia following immune checkpoint inhibitor therapy—Incidence, aetiology and assessment. Diabetic medicine. 40 (4), p. n/a. [Online].